Neutra Corp. (NTRR) Stock Price & Analysis
Neutra Corp. (NTRR) fell 50.00% to USD 0 as of July 25, 2026 at 07:14 UTC, according to Nexqual real-time market data.
NTRR last closed at USD 0; the session ranged USD 0–0 on volume of 3,000 shares. Market capitalization is $291,790, with a 52-week range of USD 0–0 (OID). Source: Nexqual, July 25, 2026 at 07:14 UTC.
Key Statistics (as of July 25, 2026 at 07:14 UTC)
| Price | USD 0 |
|---|---|
| Change | ▼ 50.00% (down) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 3,000 shares |
| Market Cap | $291,790 |
| Exchange | OID |
Technical Analysis (NTRR)
Nexqual's technical model rates NTRR "SELL" based on 1 bullish and 4 bearish signals across 124 daily candles, as of July 25, 2026 at 07:14 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 45.68 (neutral) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (NTRR)
Wall Street analysts rate NTRR "None", per Nexqual as of July 25, 2026 at 07:14 UTC.
| Consensus Rating | None |
|---|
Earnings (NTRR)
Source: Nexqual, July 25, 2026 at 07:14 UTC.
Financials & Fundamentals (NTRR)
| Total Revenue | $66,067 |
|---|---|
| Revenue Growth (YoY) | +454.20% |
| Gross Margin | +64.31% |
| Operating Margin | -47.83% |
| Profit Margin | -269.15% |
| Current Ratio | 0 |
| Total Cash | $333 |
| Total Debt | $12,314 |
| Free Cash Flow | $118,067 |
Source: Nexqual, July 25, 2026 at 07:14 UTC.
Financial Health Score (NTRR)
Nexqual rates Neutra Corp.'s overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 07:14 UTC.
| Growth | Strong — Revenue +454% YoY (latest Q) |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — $333 cash, no debt |
| Cash Flow | Strong — FCF $118K, 179% margin |
| Efficiency | Mixed — No data |
Ownership (NTRR)
| Insider Ownership | +0.69% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 2.92B |
| Float | 2.90B |
Source: Nexqual, July 25, 2026 at 07:14 UTC.
Leadership (NTRR)
Neutra Corp. is led by Sydney Jim (age 41), CEO, President, Secretary, Treasurer, Principal Finance & Accounting Officer and Sole Director, per Nexqual as of July 25, 2026 at 07:14 UTC.
| CEO, President, Secretary, Treasurer, Principal Finance & Accounting Officer and Sole Director | Sydney Jim (age 41) |
|---|
From Neutra Corp.'s Latest SEC 10-K Filing (filed 2024-08-02)
Key Strengths & Strategy (as disclosed to the SEC)
- However:   - 5 - Table of Contents   (a)  FDA:  The US Food and Drug Administration ("FDA") has stated that although hemp is no longer an illegal substance under the Farm Bill, the FDA continues to regulate cannabis products under the Food, Drug, and Cosmetic Act ("FD&C Act") and Section 351 of the Public Health Service Act.
- We intend to entrust the manufacturing to a nutraceutical contractor to private label all of our products and to sell them under our unique brand.
Partnerships
- From lighting to dosage devices, from pesticide replacements to plant enhancers, Neutra Corp. is constantly combing the industry for the latest and greatest to test, prove and bring to market.   On January 23, 2018, we entered into an agreement with Artillery Labs to sell and market natural nutraceuticals online.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PLPL | Plandai Biotechnology, Inc. | USD 0 | ▲ 0% |
| EDXC | ENDEXX Corp. | USD 0 | ▲ 0% |
| ZDPY | Zoned Properties, Inc. | USD 0.47 | ▲ 0% |
| MNTR | Mentor Capital, Inc. | USD 0.03 | ▲ 0% |
| TERS | Tersis Technologies Inc. | USD 0.25 | ▼ 24.24% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 07:14 UTC. This page is informational and not investment advice.